0001415889-22-000507.txt : 20220112
0001415889-22-000507.hdr.sgml : 20220112
20220112172147
ACCESSION NUMBER: 0001415889-22-000507
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220111
FILED AS OF DATE: 20220112
DATE AS OF CHANGE: 20220112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOTSON JERROLD DUANE
CENTRAL INDEX KEY: 0001388853
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 22527266
MAIL ADDRESS:
STREET 1: 5 CENTERPOINTE DRIVE
STREET 2: SUITE 400
CITY: LAKE OSWEGO
STATE: OR
ZIP: 97035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-01122022_020137.xml
X0306
4
2022-01-11
0001411685
VistaGen Therapeutics, Inc.
VTGN
0001388853
DOTSON JERROLD DUANE
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
VP, CFO AND SECRETARY
Common Stock
2022-01-11
4
M
0
18750
1
A
94571
D
Stock Option (Right to Buy)
1
2022-01-11
4
M
0
18750
0
D
2029-05-23
Common Stock
34375
15625
D
25% of the shares subject to this stock option vested May 23, 2019, with the the remaining shares vesting in 1/36th installments on each monthly anniversary thereafter.
/s/ Jerrold D. Dotson
2022-01-12